GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » Scaled Net Operating Assets

Shenzhen YHLO Biotech Co (SHSE:688575) Scaled Net Operating Assets : 0.74 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shenzhen YHLO Biotech Co's operating assets for the quarter that ended in Sep. 2024 was ¥3,618 Mil. Shenzhen YHLO Biotech Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥641 Mil. Shenzhen YHLO Biotech Co's Total Assets for the quarter that ended in Jun. 2024 was ¥4,041 Mil. Therefore, Shenzhen YHLO Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.74.


Shenzhen YHLO Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co Scaled Net Operating Assets Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.83 0.79 0.95 0.73 0.60

Shenzhen YHLO Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.67 0.69 0.67 0.74

Competitive Comparison of Shenzhen YHLO Biotech Co's Scaled Net Operating Assets

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's Scaled Net Operating Assets falls into.



Shenzhen YHLO Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shenzhen YHLO Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(3238.834-714.907)/4213.67
=0.60

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3806.083 - 567.249
=3238.834

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1272.508 - 385.46 - 172.141
=714.907

Shenzhen YHLO Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(3618.171-641.193)/4040.539
=0.74

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4087.553 - 469.382
=3618.171

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1487.675 - 540.835 - 305.647
=641.193

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen YHLO Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Song Yong Bo Directors, senior managers
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines